Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up (Q37489008)

20 August 2017

1 reference

title

Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. (English)

1 reference

ESMO Guidelines Working Group

20 August 2017

0 references

series ordinal

4

object named as

ESMO Guidelines Working Group

1 reference

20 August 2017

S Bielack

1

1 reference

20 August 2017

D Carrle

series ordinal

2

1 reference

20 August 2017

P G Casali

series ordinal

3

1 reference

20 August 2017

publication date

1 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

20 Suppl 4

1 reference

20 August 2017

page(s)

137-139

1 reference

Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Common musculoskeletal tumors of childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Delaying surgery with chemotherapy for osteosarcoma of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Osteosarcoma: the same old drugs or more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Complexities in interpretation of osteosarcoma clinical trial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Osteosarcoma over the age of forty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Current strategies of chemotherapy in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP154

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDP154

1 reference

20 August 2017

1 reference